elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
Drug repositioning
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Drug repositioning
RIS
0.001
(Research Intensity Score)
Papers
68
Top papers
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 · 1498 citations
Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
2021 · 245 citations
Therapeutic innovation in drug repurposing: Challenges and opportunities
2025 · 35 citations
Leishmaniases: Strategies in treatment development
2025 · 31 citations
Metal compounds as antimicrobial agents: ‘smart’ approaches for discovering new effective treatments
2025 · 26 citations
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
2021 · 176 citations
A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection
2020 · 239 citations
The combination of disulfiram and copper for cancer treatment
2020 · 195 citations
Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics
2022 · 74 citations
Newest papers
Glaucoma Drug Target Prioritisation Informs Disease-specific Therapeutic Potentials of Targeting SMAD4
2026 · 1 citations
Repurposing a Nonessential Amino Acid γ-Aminobutyric Acid To Treat Multidrug-Resistant Bacteria
2026 · 2 citations
Integrated computational and preclinical evaluation of drug repurposing candidates for KRAS-mutant non-small cell lung cancer
2026
4-Hydroxytamoxifen suppresses the malignant progression of lung adenocarcinoma by inhibiting MAPK signaling pathway
2026
Multi-target drug discovery of Sclerocarya birrea bioactive moieties against drug resistance in triple-negative breast cancer (TNBC) targeting BCL2, CASP3, and JUN modulation; a polypharmacological and molecular modelling approach
2026
Disarming Pseudomonas aeruginosa: repurposing vardenafil, valsartan, and olmesartan as anti-virulence and antibiofilm agents
2026
Drug Repurposing in Sickle Cell Disease: Evaluating Imatinib as a Therapeutic Candidate
2026
Drug repurposing for the interplay between Parkinson’s disease and epilepsy
2026
Duloxetine repositioning: Investigation of antifungal and antibiofilm activity against fluconazole-sensitive and resistant Candida Spp. strains
2026
Browse all papers →
Drug repositioning's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Drug repositioning's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link